Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.
|Number of pages||7|
|Journal||Generics and Biosimilars Initiative journal|
|Early online date||25 Sep 2019|
|Publication status||E-pub ahead of print - 25 Sep 2019|
- health policies